ClinicalTrials.gg
Sign In

Urogenital Neoplasms clinical trials

The registry lists 173 studies for Urogenital Neoplasms across more than 10 countries. 47 are recruiting or about to start. 16 of them are mainly about Urogenital Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 30 narrower conditions too, such as Prostatic Neoplasms: 17,880 studies, 4,296 open.

Get an email when these change. Save the Urogenital Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
60
Recruiting
45
Active, not recruiting
24
Terminated
21
Status unknown
13
Withdrawn
6

Phase

Phase 2
52
Phase 1
37
Phase 3
15
Early Phase 1
2
Phase 4
2

Where

United States
95
Canada
22
France
13
United Kingdom
12
Belgium
12
Spain
11

Who runs them

National Cancer Institute (NCI) (10) · M.D. Anderson Cancer Center (7) · Steba Biotech S.A. (6) · University Health Network, Toronto (5) · NanOlogy, LLC (4) · Dana-Farber Cancer Institute (3) · KU Leuven (3) · British Columbia Cancer Agency (3)

What is being tested here

Drugs under test in Urogenital Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pembrolizumab414
Riluzole202
Nivolumab106
Ipilimumab104
Cabozantinib103
Vedolizumab102
Atezolizumab102
Rivaroxaban111
Therapeutic Tumor Infiltrating Lymphocytes101
Androgen Receptor-targeting Regulated Induced Proximity Targeting Chimera HLD-0915101

Drug classes tested here Immune checkpoint inhibitors 6 open · Tyrosine kinase inhibitors (TKIs) 2 open · Antimetabolites 5 · Antimitotic agents 5 · PARP inhibitors 3

Coming up

6phase 3 studies under way
28studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 45 Urogenital Neoplasms studies recruiting now, 37 (82%) set no upper age limit and 6 (13%) stop at 75 or younger. 2 (4%) take children under 18. 4 (9%) are for women only and 9 (20%) for men only; 2 (4%) take healthy volunteers.

Recruiting studies that take each age, of 45
AgeWomenMen
102 (4%)2 (4%)
1835 (78%)39 (87%)
3035 (78%)39 (87%)
4035 (78%)39 (87%)
5035 (78%)40 (89%)
6534 (76%)40 (89%)
7532 (71%)38 (84%)
8529 (64%)35 (78%)

Across all 173 studies, recruiting or not: 8% stop at 75 or younger and 2% at 65; 7% take children; 10% are for women only and 23% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Urogenital Neoplasms studies take

Of 27 observational studies under Urogenital Neoplasms, half reached primary completion within 50 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase41 mo20–… · 23 studies——
Observational50 mo24–65 · 27 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 173. Browse all 173 → or search them.